Pfizer-BioNTech to Finalise COVID-19 Vaccine Distribution Across Europe by September-2021

Be the First to Comment Read

Pfizer-BioNTech to Finalise COVID-19 Vaccine Distribution Across Europe by September-2021

The supply of initial 200 million doses of BNT162b2, the COVID-19 vaccine manufactured by Pfizer Inc (NYSE:PFE) and BioNTech SE (Nasdaq:BNTX), is anticipated to be finalized by September 2021 across Europe, according to some media reports.

Meanwhile, Most European countries have already started inoculating healthcare workers and vulnerable people with the Pfizer-BioNTech vaccine.

Furthermore, the European Union has signed advance buying agreements with Pfizer-BioNTech, AstraZeneca, CureVac, J&J, Moderna, and Sanofi for a total of almost 2 billion doses.

However, the media reports say that discussions are ongoing regarding the delivery of a further 100 million doses and had not been concluded yet.

On 10 December 2020, the US Food and Drug Administration (FDA) had granted the EUA (emergency use authorization) to Pfizer-BioNTech’s COVID-19 Vaccine in the U.S.

Lately, the government of the United States had ordered additional 100 million shots of BNT162b2, bringing total doses for the nation to 200 million.

Disclaimer

Speak your Mind

Ad
kalkine logo

GET A FREE STOCK REPORT

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK